The prospective longitudinal follow-up study of PD patients with or without the LRRK2 G2019S mutation by Saunders-Pullman et al. (2018) from the cross-sectional study, shows a slower decline in motor UPDRS scores among those PD patients with LRRK2 G2019S. The gene discussed is LRRK2; the disease is Parkinson disease.